Tilray Brands (TLRY) Net Income towards Common Stockholders (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Net Income towards Common Stockholders (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 42.01% |
| Nov 30, 2025 | -2,975.68% |
| Aug 31, 2025 | 100.25% |
| May 31, 2025 | 22.66% |
| Feb 28, 2025 | -830.56% |
| Nov 30, 2024 | -146.09% |
| Aug 31, 2024 | 36.12% |
| May 31, 2024 | 48.33% |
| Feb 29, 2024 | -127.32% |
| Nov 30, 2023 | 17.33% |
| Aug 31, 2023 | 53.38% |
| May 31, 2023 | 89.98% |
| Feb 28, 2023 | -1,305.76% |
| Nov 30, 2022 | -29.28% |
| Aug 31, 2022 | 85.63% |
| May 31, 2022 | -972.42% |
| Feb 28, 2022 | 805.21% |
| Nov 30, 2021 | 116.75% |
| Aug 31, 2021 | -496.56% |
| May 31, 2021 | -78.18% |